🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

55 results for “intervention” Clear

  1. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Use

    phase 3 other completed

    1 trial

  2. Drug use prevention intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Adolescent Behavior

    phase 3 other completed

    1 trial

  3. Educational Intervention

    United Therapeutics Europe Ltd

    Hematologic Malignancies

    phase 3 other active

    1 trial

  4. HEPARIN , NADROPARIN

    Disc Medicine

    All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.

    phase 3 small molecule active

    1 trial

  5. Intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV

    phase 3 other active

    1 trial

  6. Intervention - a validated home BP monitor and support from the specialist nurse

    United Therapeutics Europe Ltd

    Stroke

    phase 3 other completed

    1 trial

  7. Peer Mentoring Intervention for HCV-Infected IDUs

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    phase 3 other completed

    1 trial

  8. Standard Brief Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Usage

    phase 3 other completed

    1 trial

  9. Standard Care Intervention (SCI)

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 3 other completed

    1 trial

  10. behavior intervention and male circumcision

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV

    phase 3 other active

    1 trial

  11. Brief computer-delivered intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 2 other completed

    1 trial

  12. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use

    phase 2 other completed

    1 trial

  13. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse Detection

    phase 2 other completed

    1 trial

  14. Cognitive Behavioral Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

  15. Combined intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 other completed

    1 trial

  16. Computer-delivered brief intervention (5As)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 2 other completed

    1 trial

  17. FINGER 2.0 multidomain lifestyle-based intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Cognitive Decline

    phase 2 other active

    1 trial

  18. Interactive injection and sexual risk intervention

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  19. Intervention A Fluoxetine Hydrochloride (HCl)

    Adaptive Biotechnologies Corp

    Post Traumatic Stress Disorder

    phase 2 small molecule active

    2 trials

  20. Intervention B Vilazodone Hydrochloride (HCl)

    Adaptive Biotechnologies Corp

    Post Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial

  21. Intervention C Daridorexant

    Adaptive Biotechnologies Corp

    Post Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial

  22. Intervention Condition

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  23. Intervention D SLS-002

    Adaptive Biotechnologies Corp

    Post Traumatic Stress Disorder

    phase 2 small molecule on hold

    1 trial

  24. Monitoring and Feedback Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources